Item | Group 1 (heparin) | Group 2 (TauroLockā¢) | P value |
---|---|---|---|
No. of BSI events | 30 | 25 | Ā |
No. (%) of patients with at least 1 BSI | 24 (27) | 21 (24) | 0.74 |
No. (%) of BSI with CoNS* or MRSEĀ§ | 14 (47) | 3 (11) | 0.004 |
Ā | āāāCoNS: 4 (13) | āāāCoNS: 3 (11) | Ā |
Ā | āāāMRSE: 10 (33) | āāāMRSE: 0 (0) | Ā |
Incidence densityā” for All BSI events (CI95) | 4.93 (3.33ā7.04) | 3.82 (2.52ā5.56) | 0.35 |
Incidence densityā” calculated with the number of specific isolates | Ā | Ā | Ā |
āāāBSI with CoNS/MRSE | 2.30 (1.26ā3.86) | 0.45 (0.09ā1.31) | 0.004 |
āāāBSI other Gram positive | 0.66 (0.18ā1.68) | 1.19 (0.52ā2.35) | 0.32 |
āāāBSI E. coli | 0.66 (0.18ā1.68) | 1.49 (0.72ā2.74) | 0.15 |
āāāBSI all Gram negative | 1,97 (1.02ā3.44) | 2.24 (1.25ā3.69) | 0.74 |